Cargando…

Regulation of IMP3 by EGFR Signaling and Repression by ERβ: Implications for Triple Negative Breast Cancer

Insulin-like growth factor II (IGF-II) mRNA binding protein 3 (IMP3) is emerging as a useful indicator of the progression and outcome of several cancers. IMP3 expression is associated with triple-negative breast carcinomas (TNBCs), which are aggressive tumors associated with poor outcome. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samanta, Sanjoy, Sharma, Vishva M., Khan, Ashraf, Mercurio, Arthur M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337950/ https://www.ncbi.nlm.nih.gov/pubmed/22266872 http://dx.doi.org/10.1038/onc.2011.620

Ejemplares similares

ERβ regulation of NF-κB activation in prostate cancer is mediated by HIF-1
por: Mak, Paul, et al.
Publicado: (2015)

IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer
por: Samanta, Sanjoy, et al.
Publicado: (2018)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research
por: Yan, Shunchao, et al.
Publicado: (2023)

ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
por: Thomas, Christoforos, et al.
Publicado: (2012)

Characterization of Three Novel IMP Metallo-β-Lactamases, IMP-89, IMP-91, and IMP-96, and Diverse bla(IMP)-Carrying Accessory Genetic Elements from Chinese Clinical Isolates
por: Li, Xinyue, et al.
Publicado: (2023)

Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases
por: Yamamoto, Keizo, et al.
Publicado: (2022)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
por: Reese, Jordan M., et al.
Publicado: (2017)

The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-β-lactamase gene bla(IMP-6), leading to a carbapenem-susceptible phenotype in the bla(IMP-6)-positive Escherichia coli strain A56-1S
por: Segawa, Takaya, et al.
Publicado: (2018)

IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae
por: Kubota, Hiroaki, et al.
Publicado: (2019)

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
por: Wang, Li, et al.
Publicado: (2016)

Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer
por: Salahuddin, Ahmad, et al.
Publicado: (2022)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene
por: Roberts, Melyssa S., et al.
Publicado: (2020)

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2022)

Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation
por: Kim, Wantae, et al.
Publicado: (2017)

PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients
por: Tonetti, Debra A., et al.
Publicado: (2012)

Specific Cooperation Between Imp-α2 and Imp-β/Ketel in Spindle Assembly During Drosophila Early Nuclear Divisions
por: Virágh, Erika, et al.
Publicado: (2012)

Imps at large
Publicado: (1978)

Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
por: Mishra, Ameet K., et al.
Publicado: (2016)

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations
por: Wang, Zhijie, et al.
Publicado: (2015)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
por: Scarpetti, Lauren, et al.
Publicado: (2023)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase
por: Softley, Charlotte A., et al.
Publicado: (2020)

RNA-hydrolyzing activity of metallo-β-lactamase IMP-1
por: Kato, Yoshiki, et al.
Publicado: (2020)

Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: Predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii
por: Cañada-García, Javier E., et al.
Publicado: (2022)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
por: Linklater, Erik S., et al.
Publicado: (2016)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017)

IMP museo petrolero :
por: Avendaño Arroyo, César David
Publicado: (2010)

Weak decays of IMPS
por: Peccei, Roberto D
Publicado: (1980)

Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα
por: Logotheti, Stella, et al.
Publicado: (2012)

Emergence of Citrobacter freundii carrying IMP-8 metallo-β-lactamase in Germany
por: Peter, S, et al.
Publicado: (2014)

ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
por: Bado, Igor, et al.
Publicado: (2016)

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
por: Song, Wei, et al.
Publicado: (2017)

Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
por: El Guerrab, Abderrahim, et al.
Publicado: (2011)

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
por: Teng, Yvonne Hui-Fang, et al.
Publicado: (2011)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ioioi3ln70h78oqd689sv7soj